Coagulopathy After Cardiopulmonary Bypass in Jehovah’s Witness Patients: Management of Two Cases Using Fractionated Components and Factor VIIa
- 1 April 2007
- journal article
- case report
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 104 (4) , 763-765
- https://doi.org/10.1213/01.ane.0000250913.45299.f3
Abstract
Changes in the Jehovah's Witness (JW) blood refusal policy now give members the personal choice to accept certain processed fractions of blood, such as factor concentrates and cryoprecipitate. Two JW patients undergoing complex aortic surgery who developed severe microvascular bleeding after prolonged use of cardiopulmonary bypass were treated with recombinant activated factor VII, cryoprecipitate, and antithrombin concentrate. Cardiopulmonary bypass-induced coagulopathy was successfully treated, allowing chest closure without evidence of thrombotic complications. Processed blood fractions can be a valuable adjuvant to drugs when treating bleeding in JW patients.Keywords
This publication has 11 references indexed in Scilit:
- Use of Recombinant Activated Factor VII for Bleeding Following Operations Requiring Cardiopulmonary BypassChest, 2005
- Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet countJournal of Thrombosis and Haemostasis, 2005
- A Phase III, Double-blind, Placebo-controlled, Multicenter Study on the Efficacy of Recombinant Human Antithrombin in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary BypassAnesthesiology, 2005
- Dosing with recombinant factor viia based on current evidenceSeminars in Hematology, 2004
- Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®)Anesthesiology, 2003
- Multidisciplinary management of a Jehovah’s Witness patient for the removal of a renal cell carcinoma extending into the right atriumCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2002
- Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgeryThrombosis Research, 2002
- Use of desmopressin and erythropoietin in an anaemic Jehovah’s Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacementPerfusion, 2001
- Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's WitnessesBMJ, 2001
- Activation of Coagulation and Fibrinolysis During Cardiothoracic OperationsPublished by Elsevier ,1998